Nanogrowbiotech

1 known investors

NanoGrow Biotech develops biological therapies based on a single-domain antibody (nanobody) platform, combined with various formulations such as topical, inhaled, injectable, and oral delivery. Its targeted therapies address conditions including psoriasis, asthma, inflammatory bowel disease, and melanoma.